Latest KFF Health News Content

Latest KFF Health News Stories

Illustrating Illinois Insurance Coverage Before & After Health Law

KFF Health News Original

Health care advocates in Illinois are marking the two-year anniversary of the 2010 health law with an interactive map that shows how two provisions  –  expansion of Medicaid eligibility and the creation of new insurance marketplaces called exchanges – could expand coverage to the state’s residents, some 13 percent of whom are currently uninsured. The map […]

Today’s Headlines – March 20, 2012

KFF Health News Original

The Washington Post: House Republicans To Propose Dramatic Changes To Tax Code Democrats have been gearing up to tackle other aspects of Ryan’s budget proposal — notably efforts to reshape Medicare and to slash federal agency spending beneath the $1.047 trillion level agreed to during the summer’s hard-fought battle over raising the debt ceiling (Helderman […]

Marking The Health Law’s Second Anniversary

Morning Briefing

As the health law turns 2, media outlets report on what the future might hold. Meanwhile, the Department of Health and Human Services steps up its messaging related to the measure’s benefits.

Six State Attorneys General To Hear Supreme Court Health Law Arguments

Morning Briefing

Attorneys general from six states will sit in the Supreme Court to hear the oral arguments over the health reform law. In the meantime, Pennsylvania lawmakers may offer a constitutional amendment to ban laws mandating that people have health insurance.

State Lawmkers Consider Abortion, Contraception Legislation

Morning Briefing

Lawmakers in Arizona and Tennessee are considering bills that would allow employers to deny contraception coverage on religious grounds and require the state publish the names of doctors who perform abortions, respectively.

USAID World TB Day Website

Morning Briefing

USAID’s website features a page dedicated to World TB Day, which will be commemorated on March 24. The page lists information on upcoming events, as well as links to several reports, such as the FY2010 Report to Congress on the Global TB Context (.pdf), stories, and features (3/19).

Center for Global Health Policy Interviews TB Expert In Advance Of World TB Day

Morning Briefing

The Center for Global Health Policy’s “Science Speaks” blog interviews tuberculosis (TB) expert Lee Reichman, founding executive director of the New Jersey Medical School Global Tuberculosis Institute, in advance of World TB Day, to be observed on March 24. According to the blog, Reichman discusses “the spread of drug-resistant TB and what he thinks are the most promising advances coming down the scientific pipeline” (Mazzotta, 3/19).

Reuters Examines Global Rise In Drug-Resistant Tuberculosis Cases

Morning Briefing

“[O]ften seen in the wealthy West as a disease of bygone eras,” Reuters examines rising rates of tuberculosis (TB) — drug-resistant TB in particular — among the world’s rich and poor. “[R]apidly rising rates of drug-resistant TB in some of the wealthiest cities in the world, as well as across Africa and Asia, are again making history,” Reuters writes. According to the news service, “London has been dubbed the ‘tuberculosis capital of Europe,’ and a startling recent study documenting new cases of so-called ‘totally drug-resistant’ TB in India suggests the modern-day tale of this disease could get a lot worse.”

Excluded From WHO Targets, Children At Risk Of Being Forgotten In Global NCD Agenda

Morning Briefing

Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her “Global Health Blog,” writing, “Children die from cancer, heart disease and other [NCDs] but they are in danger of being forgotten as global targets for action are drawn up, say health groups.” Boseley discusses an analysis by advocate Kate Armstrong, which suggests “the targets now being considered by the [WHO] and others to reduce the impact of heart disease, cancer and other [NCDs] are in danger of being focused solely on adults,” as “the targets under consideration aim to bring down the deaths of adults over the age of 30.”

TB Alliance Launches Phase II Clinical Trial To Test New Drug Regimen Among People With TB, MDR-TB

Morning Briefing

The TB Alliance on Monday announced it has launched a Phase II clinical trial “of a new treatment regimen for tuberculosis, including for patients with resistance to existing multi-drug programs,” Agence France-Presse reports. “The new regimen being tested could shorten required treatment to as little as four months in both patients with TB and some forms of drug-resistant TB, compared with the current six to 24 months,” the news agency writes, adding, “Costs will also be vastly reduced.” The trial “will take place at eight sites in South Africa, Tanzania, and Brazil, the alliance said,” AFP notes (Santini, 3/19).